Integrase inhibitors hand us a new HIV clinical puzzle
- PMID: 35688165
- DOI: 10.1016/S2352-3018(22)00122-9
Integrase inhibitors hand us a new HIV clinical puzzle
Conflict of interest statement
WDFV reports grants from US Agency for International Development (USAID), Unitaid, the South African Medical Research Council (SAMRC), National Institutes of Health, Bill & Melinda Gates Foundation, and ViiV; personal fees and non-financial support from ViiV and Gilead Sciences; and personal fees from Mylan, Merk, Adcock-Ingram, Aspen, Abbott, Roche, Johnson & Johnson, Sanofi, and Virology Education. SS reports grants from USAID, Unitaid, SAMRC, Bill & Melinda Gates Foundation, and ViiV. JN reports grants from Wellcome Trust and Bill & Melinda Gates Foundation and personal fees from Mylan, Cipla, Johnson & Johnson, AbbVie, and Virology Education.
Comment on
-
Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium.Lancet HIV. 2022 Jul;9(7):e474-e485. doi: 10.1016/S2352-3018(22)00094-7. Epub 2022 Jun 7. Lancet HIV. 2022. PMID: 35688166
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical